Barclays Maintains an 'Overweight' on Acme Packet (APKT); Moving Ahead of Setbacks
Get Alerts APKT Hot Sheet
Price: $29.24 --0%
Rating Summary:
3 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Acme Packet (NASDAQ: APKT) price target raised from $33 to $35.
Analyst, Jeff Kvaal, said, "Following a string of setbacks, 1Q12 sales of $71M were in line if not slightly better than expectations. Reaffirmed guidance for 10% 2012 sales growth embeds caution on carrier spending as visibility has not changed near term. Management does expect a sharp 2H12 ramp as spending accelerates."
FY12 EPS estimate lowered from $1.02 to $0.98 and FY13 maintained at $1.39.
For an analyst ratings summary and ratings history on Acme Packet click here. For more ratings news on Acme Packet click here.
Shares of Acme Packet closed at $28.22 yesterday.
Analyst, Jeff Kvaal, said, "Following a string of setbacks, 1Q12 sales of $71M were in line if not slightly better than expectations. Reaffirmed guidance for 10% 2012 sales growth embeds caution on carrier spending as visibility has not changed near term. Management does expect a sharp 2H12 ramp as spending accelerates."
FY12 EPS estimate lowered from $1.02 to $0.98 and FY13 maintained at $1.39.
For an analyst ratings summary and ratings history on Acme Packet click here. For more ratings news on Acme Packet click here.
Shares of Acme Packet closed at $28.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share